Disease burden in patients with type 2 diabetes is largely driven by the associated long-term complications, making glycemic control an invaluable treatment goal. In 2005, the first incretin-based agent was introduced into the type 2 diabetes treatment landscape to address postprandial glucose control. Incretin-based therapies work through modulation of gut-derived hormones that play a role in maintaining euglycemia and regulating hormones. Incretin-based therapy plays a major role in managing patients with type 2 diabetes and has become a popular choice for controlling blood glucose levels because of its glycemic efficacy, ease of use, and low risk for hypoglycemia.
How familiar are you with this therapeutic approach to type 2 diabetes? Test your knowledge with this quick quiz.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Romesh Khardori, Anne L. Peters. Fast Five Quiz: Type 2 Diabetes Incretin-Based Therapy - Medscape - Apr 28, 2023.